These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25784542)

  • 21. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
    Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
    J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential epigenetic and transcriptional response of the skeletal muscle carnitine palmitoyltransferase 1B (CPT1B) gene to lipid exposure with obesity.
    Maples JM; Brault JJ; Witczak CA; Park S; Hubal MJ; Weber TM; Houmard JA; Shewchuk BM
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E345-56. PubMed ID: 26058865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capric Acid Up-Regulates UCP3 Expression without PDK4 Induction in Mouse C2C12 Myotubes.
    Abe T; Hirasaka K; Kohno S; Tomida C; Haruna M; Uchida T; Ohno A; Oarada M; Teshima-Kondo S; Okumura Y; Choi I; Aoyama T; Terao J; Nikawa T
    J Nutr Sci Vitaminol (Tokyo); 2016; 62(1):32-9. PubMed ID: 27117849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
    Sugimoto K; Kazdová L; Qi NR; Hyakukoku M; Kren V; Simáková M; Zídek V; Kurtz TW; Pravenec M
    J Hypertens; 2008 Jun; 26(6):1209-15. PubMed ID: 18475159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance.
    Bruce CR; Hoy AJ; Turner N; Watt MJ; Allen TL; Carpenter K; Cooney GJ; Febbraio MA; Kraegen EW
    Diabetes; 2009 Mar; 58(3):550-8. PubMed ID: 19073774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes.
    Kadotani A; Tsuchiya Y; Hatakeyama H; Katagiri H; Kanzaki M
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1291-303. PubMed ID: 19755671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation.
    Coll T; Jové M; Rodríguez-Calvo R; Eyre E; Palomer X; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
    Diabetes; 2006 Oct; 55(10):2779-87. PubMed ID: 17003343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.
    Staiger H; Haas C; Machann J; Werner R; Weisser M; Schick F; Machicao F; Stefan N; Fritsche A; Häring HU
    Diabetes; 2009 Mar; 58(3):579-89. PubMed ID: 19074989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.
    Itahana Y; Yeh ET; Zhang Y
    Mol Cell Biol; 2006 Jun; 26(12):4675-89. PubMed ID: 16738331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
    Risérus U; Sprecher D; Johnson T; Olson E; Hirschberg S; Liu A; Fang Z; Hegde P; Richards D; Sarov-Blat L; Strum JC; Basu S; Cheeseman J; Fielding BA; Humphreys SM; Danoff T; Moore NR; Murgatroyd P; O'Rahilly S; Sutton P; Willson T; Hassall D; Frayn KN; Karpe F
    Diabetes; 2008 Feb; 57(2):332-9. PubMed ID: 18024853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
    Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
    Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cilostazol induces mitochondrial fatty acid β-oxidation in C2C12 myotubes.
    Wang B; Zhu L; Sui S; Sun C; Jiang H; Ren D
    Biochem Biophys Res Commun; 2014 May; 447(3):441-5. PubMed ID: 24732360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of PPARdelta up-regulates fatty acid oxidation and energy uncoupling genes of mitochondria and reduces palmitate-induced apoptosis in pancreatic beta-cells.
    Wan J; Jiang L; Lü Q; Ke L; Li X; Tong N
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1567-72. PubMed ID: 20040361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
    Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [PPARs Mediate the Regulation of Energy Metabolism By Long-Chain Fatty Acids].
    Yan Y; Wang ZB; Tang CK
    Sheng Li Ke Xue Jin Zhan; 2016 Feb; 47(1):1-6. PubMed ID: 27424398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
    Hirabara SM; Curi R; Maechler P
    J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.